Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eija-Riitta Salomaa

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Duodecim; Laaketieteellinen Aikakauskirja|November 10, 2006
[Not Available]Eija-Riitta Salomaa
Duodecim; Laaketieteellinen Aikakauskirja|August 7, 2015
[The prognosis of lung cancer continues to be poor--treatment outcome within The Hospital District of Southwest Finland in 2004 to 2011]Eija-Riitta Salomaa, Maija Walta
Duodecim; Laaketieteellinen Aikakauskirja|January 20, 2007
[Not Available]Eija-Riitta Salomaa, Arja Viinanen
BMC Pulmonary Medicine|September 30, 2023
Overall drug treatment of idiopathic pulmonary fibrosis patients from national registries - a real-world study from FinlandJaana Kaunisto, Eija-Riitta Salomaa, Mari Koivisto, et al.
Chest|October 21, 2005
Delays in the diagnosis and treatment of lung cancerEija-Riitta Salomaa, Susanna Sällinen, Heikki Hiekkanen, et al.
The Clinical Respiratory Journal|June 10, 2011
Pemetrexed in malignant pleural mesothelioma and the clinical outcomeAija Knuuttila, Eija-Riitta Salomaa, Suvi Saikkonen, et al.
BMC Pulmonary Medicine|August 22, 2013
Idiopathic pulmonary fibrosis--a systematic review on methodology for the collection of epidemiological dataJaana Kaunisto, Eija-Riitta Salomaa, Ulla Hodgson, et al.
European Clinical Respiratory Journal|March 23, 2017
Are physicians in primary health care able to recognize pulmonary fibrosis?Minna Purokivi, Ulla Hodgson, Marjukka Myllärniemi, et al.
Duodecim; Laaketieteellinen Aikakauskirja|December 18, 2013
[Commencement of and adherence to CPAP treatment of patients with sleep-disordered breathing]Eija-Riitta Salomaa, Minna Myllylä, Ulla Anttalainen, et al.
Duodecim; Laaketieteellinen Aikakauskirja|April 11, 2009
[Bevacizumab in the treatment of non-small cell lung cancer]Aija Knuuttila, Annamari Rouhos, Eeva-Maija Karjalainen, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Duodecim; Laaketieteellinen Aikakauskirja|November 10, 2006
[Not Available]Eija-Riitta Salomaa
Duodecim; Laaketieteellinen Aikakauskirja|August 7, 2015
[The prognosis of lung cancer continues to be poor--treatment outcome within The Hospital District of Southwest Finland in 2004 to 2011]Eija-Riitta Salomaa, Maija Walta
Duodecim; Laaketieteellinen Aikakauskirja|January 20, 2007
[Not Available]Eija-Riitta Salomaa, Arja Viinanen
BMC Pulmonary Medicine|September 30, 2023
Overall drug treatment of idiopathic pulmonary fibrosis patients from national registries - a real-world study from FinlandJaana Kaunisto, Eija-Riitta Salomaa, Mari Koivisto, et al.
Chest|October 21, 2005
Delays in the diagnosis and treatment of lung cancerEija-Riitta Salomaa, Susanna Sällinen, Heikki Hiekkanen, et al.
The Clinical Respiratory Journal|June 10, 2011
Pemetrexed in malignant pleural mesothelioma and the clinical outcomeAija Knuuttila, Eija-Riitta Salomaa, Suvi Saikkonen, et al.
BMC Pulmonary Medicine|August 22, 2013
Idiopathic pulmonary fibrosis--a systematic review on methodology for the collection of epidemiological dataJaana Kaunisto, Eija-Riitta Salomaa, Ulla Hodgson, et al.
European Clinical Respiratory Journal|March 23, 2017
Are physicians in primary health care able to recognize pulmonary fibrosis?Minna Purokivi, Ulla Hodgson, Marjukka Myllärniemi, et al.
Duodecim; Laaketieteellinen Aikakauskirja|December 18, 2013
[Commencement of and adherence to CPAP treatment of patients with sleep-disordered breathing]Eija-Riitta Salomaa, Minna Myllylä, Ulla Anttalainen, et al.
Duodecim; Laaketieteellinen Aikakauskirja|April 11, 2009
[Bevacizumab in the treatment of non-small cell lung cancer]Aija Knuuttila, Annamari Rouhos, Eeva-Maija Karjalainen, et al.
Pageof 2